Cargando…
A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy
A 39-year-old man had received boron neutron capture therapy (BNCT) for a grade II astrocytoma (compatible with diffuse astrocytoma, not otherwise specified in the WHO 2016 criteria). He returned to his previous work after surgery, but, 7 years later, he suddenly developed seizures, and his health c...
Autores principales: | Kamano, Shuji, Matsuyama, Masayuki, Minamimura, Kenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538456/ https://www.ncbi.nlm.nih.gov/pubmed/33062571 http://dx.doi.org/10.2176/nmccrj.cr.2019-0228 |
Ejemplares similares
-
Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021) -
Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023) -
Conference on Accelerator-based Neutron Sources for Boron Neutron Capture Therapy
Publicado: (1994) -
Neutron Tube Design Study for Boron Neutron Capture Therapy Application
por: Verbeke, J M, et al.
Publicado: (1999) -
Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)